Mixed trial results for Lilly’s headache drug galcanezumab
admin 16th May 2018 Uncategorised 0Lilly has reported mixed trial data for its experimental therapy galcanezumab, showing efficacy in patients with episodic cluster headaches but failing in those with chronic cluster headache. More: Mixed trial results for Lilly’s headache drug galcanezumab Source: News
read more